Influence of different doses of retinoic acid on cardiac remodeling

Nutrition

Volumn 27, Issue 7-8, 2011, Pages 824-828

  Freire, Cristiana M M ^a   Azevedo, Paula S ^a   Minicucci, Marcos F ^a   Oliveira, Silvio A ^a   Martinez, Paula F ^a   Novo, Rosangela ^a   Chiuso Minicucci, Fernanda ^a   Matsubara, Beatriz B ^a   Matsubara, Luiz S ^a   Okoshi, Katashi ^a   Novelli, Ethel L ^a   Zornoff, Leonardo A M ^a   Paiva, Sergio A R ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Cardiac remodeling; Connexin 43; Cytokines; Energetic metabolism; Retinoic acid

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; CITRATE SYNTHASE; COLLAGEN; CONNEXIN 43; GAMMA INTERFERON; LACTATE DEHYDROGENASE; RETINOIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTIC VELOCITY; ARTICLE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; ENERGY METABOLISM; FOOD COMPOSITION; HEART HYPERTROPHY; HEART INDEX; HEART LEFT ATRIUM; HEART MUSCLE METABOLISM; HEART OUTPUT; HEART SIZE; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SYSTOLIC BLOOD PRESSURE; VITAMIN INTAKE;

ANIMALS; BLOOD PRESSURE; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART ATRIA; HEART VENTRICLES; MYOCARDIUM; RATS; TRETINOIN; VENTRICULAR REMODELING; VITAMINS;

ANIMALIA; RATTUS;

EID: 79952050645     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2010.08.011     Document Type: Article

References (30)

1. Pan J., Baker K.M. Retinoic acid and the heart. Vitam Horm 2007, 75:257-283.
2. Delerive P., Frucharti J.-C., Staelsi B. Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol 2001, 169:453-459.
3. Feingold K., Kim M.S., Shigenaga J., Moser A., Grunfeld C. Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response. Am J Physiol Endocrinol Metab 2004, 286:E201-E207.
4. Nagpal S., Chandraratna R.A. Vitamin A and regulation of gene expression. Curr Opin Clin Nutr Metab Care 1998, 1:341-346.
5. Smith S.M., Dickman E.D. New insights into retinoid signaling in cardiac development and physiology. Trends Cardiovasc Med 1997, 7:324-329.
6. Lu L., Yao T., Zhu Y.Z., Huang G.Y., Zhu Y.C. Chronic all-trans retinoic acid treatment prevents medial thickening of intramyocardial and intrarenal arteries in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2003, 285:H1370-H1377.
7. Paiva S.A., Matsubara L.S., Matsubara B.B., Minicucci M.F., Azevedo P.S., Campana A.O., Zornoff L.A. Retinoic acid supplementation attenuates ventricular remodeling after myocardial infarction in rats. J Nutr 2005, 135:2326-2328.
8. Choudhary R., Palm-Leis A., Scott R.C., Guleria R.S., Rachut E., Baker K.M., et al. All-trans retinoic acid prevents development of cardiac remodeling in aortic banded rats by inhibiting the renin-angiotensin system. Am J Physiol Heart Circ Physiol 2008, 294:H633-H644.
9. de Paiva S.A., Zornoff L.A., Okoshi M.P., Okoshi K., Matsubara L.S., Matsubara B.B., et al. Ventricular remodeling induced by retinoic acid supplementation in adult rats. Am J Physiol Heart Circ Physiol 2003, 284:H2242-H2246.
10. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993, 123:1939-1951.
11. Litwin S.E., Katz S.E., Weinberg E.O., Lorell B.H., Aurigemma G.P., Douglas P.S. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure. Circulation 1995, 91:2642-2654.
12. Sahn D.J., DeMaria A., Kisslo J., Weyman A. The Committee on M-Mode Standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978, 58:1072-1083.
13. Doering C.W., Jalil J.E., Janicki J.S., Pick R., Aghili S., Abrahams C., et al. Collagen network remodelling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy. Cardiovasc Res 1988, 22:686-695.
14. Tang G., Russel M.R. 13-Cis-retinoic acid is an endogenous compound in human serum. J Lipid Res 1990, 31:175-182.
15. van Veen T.A., van Rijen H.V., Wiegerinck R.F., Opthof T., Colbert M.C., Clement S. Remodeling of gap junctions in mouse hearts hypertrophied by forced retinoic acid signaling. J Mol Cell Cardiol 2002, 34:1411-1423.
16. Bass A., Brdiczka D., Eyer P., Hofer S., Pette D. Metabolic differentiation of distinct muscle types at the level of enzymatic organization. Eur J Biochem 1969, 10:198-206.
17. Ramesh G., Reeves W.B. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 2002, 110:835-842.
18. Clark J.D., Gebhart G.F., Gonder J.C., Keeling M.E., Kohn D.F. Special report: the 1996 Guide for the Care and Use of Laboratory Animals. ILAR J 1997, 38:41-48.
19. Dorn G.W. The fuzzy logic of physiological cardiac hypertrophy. Hypertension 2007, 49:962-970.
20. McMullen J.R., Jennings G.L. Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure. Clin Exp Pharmacol Physiol 2007, 34:255-262.
21. Opie L.H., Commerford P.J., Gersh B.J., Pfeffer M.A. Controversies in ventricular remodelling. Lancet 2006, 367:356-367.
22. Selvetella G., Hirsch E., Notte A., Tarone G., Lembo G. Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence. Cardiovasc Res 2004, 63:373-380.
23. Cohn J.N., Ferrari R., Sharpe N. Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol 2000, 35:569-582.
24. Tansey E.E., Kwaku K.F., Hammer P.E., Cowan D.B., Federman M., Levitsky S., et al. Reduction and redistribution of gap and adherens junction proteins after ischemia and reperfusion. Ann Thorac Surg 2006, 82:1472-1479.
25. Fialová M., Dlugosová K., Okruhlicová L., Kristek F., Manoach M., Tribulová N. Adaptation of the heart to hypertension is associated with maladaptive gap junction connexin-43 remodeling. Physiol Res 2008, 57:7-11.
26. Vetterlein F., Mühlfeld C., Cetegen C., Volkmann R., Schrader C., Hellige G. Redistribution of connexin43 in regional acute ischemic myocardium: influence of ischemic preconditioning. Am J Physiol Heart Circ Physiol 2006, 291:H813-H819.
27. Severs N.J., Bruce A.F., Dupont E., Rothery S. Remodelling of gap junctions and connexin expression in diseased myocardium. Cardiovasc Res 2008, 80:9-19.
28. Dinh W., Futh R., Nickl W., Krahn T., Ellinghaus P., Scheffold T., et al. Elevated plasma levels of TNF-alpha and interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders. Cardiovasc Diabetes 2009, 8:1-7.
29. Van Bilsen M., van Nieuwenhoven F.A., van der Vusse G.J. Metabolic remodeling of the heart: beneficial or detrimental?. Cardiovasc Res 2009, 81:420-428.
30. Stanley W.C., Recchia F.A., Lopaschuk G.D. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 2005, 85:1093-1129.